Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.

Charytan DM, Natwick T, Solid CA, Li S, Gong T, Herzog CA.

Am J Kidney Dis. 2019 Jun 26. pii: S0272-6386(19)30738-3. doi: 10.1053/j.ajkd.2019.04.018. [Epub ahead of print]

PMID:
31255335
2.

Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study.

Ying T, Gill J, Webster A, Kim SJ, Morton R, Klarenbach SW, Kelly P, Ramsay T, Knoll GA, Pilmore H, Hughes G, Herzog CA, Chadban S, Gill JS.

Am Heart J. 2019 May 22;214:175-183. doi: 10.1016/j.ahj.2019.05.008. [Epub ahead of print]

PMID:
31228771
3.

Congestive Heart Failure and Chronic Kidney Disease: The CardioRenal/NephroCardiology Connection.

Herzog CA.

J Am Coll Cardiol. 2019 Jun 4;73(21):2701-2704. doi: 10.1016/j.jacc.2019.03.474. No abstract available.

PMID:
31146815
4.

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.

Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

PMID:
31053387
5.

Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.

Jukema JW, Timal RJ, Rotmans JI, Hensen LCR, Buiten MS, de Bie MK, Putter H, Zwinderman AH, van Erven L, Krol-van Straaten MJ, Hommes N, Gabreëls B, van Dorp W, van Dam B, Herzog CA, Schalij MJ, Rabelink TJ; ICD2 Trial Investigators.

Circulation. 2019 Jun 4;139(23):2628-2638. doi: 10.1161/CIRCULATIONAHA.119.039818. Epub 2019 Mar 18.

PMID:
30882234
6.

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population.

Li S, Peng Y, Wang X, Qian Y, Xiang P, Wade SW, Guo H, Lopez JAG, Herzog CA, Handelsman Y.

Clin Cardiol. 2019 Mar;42(3):391-399. doi: 10.1002/clc.23160. Epub 2019 Feb 25.

7.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
8.

Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.

Bagai A, Lu D, Lucas J, Goyal A, Herzog CA, Wang TY, Goodman SG, Roe MT.

J Am Heart Assoc. 2018 Dec 18;7(24):e010394. doi: 10.1161/JAHA.118.010394.

9.

Flow convergence visualized in mitral regurgitation with spontaneous echo contrast.

Smith AAH, Megaly M, Madsen M, Waska A, Bart BA, Herzog CA.

Int J Cardiovasc Imaging. 2019 Mar;35(3):439-440. doi: 10.1007/s10554-018-1463-5. Epub 2018 Oct 4. No abstract available.

PMID:
30288665
10.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.

Bangalore S, Maron DJ, Fleg JL, O'Brien SM, Herzog CA, Stone GW, Mark DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman JS; ISCHEMIA-CKD Research Group.

Am Heart J. 2018 Nov;205:42-52. doi: 10.1016/j.ahj.2018.07.023. Epub 2018 Aug 1.

11.

Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Wanner C, Herzog CA, Turakhia MP; Conference Steering Committee.

Kidney Int. 2018 Aug;94(2):231-234. doi: 10.1016/j.kint.2018.05.005. Epub 2018 Jun 21. No abstract available.

PMID:
29935952
12.

Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.

Herzog CA, Natwick T, Li S, Charytan DM.

JACC Cardiovasc Imaging. 2018 Jun 8. pii: S1936-878X(18)30369-3. doi: 10.1016/j.jcmg.2018.04.012. [Epub ahead of print]

PMID:
29909107
13.

Cardiovascular Outcomes Reported in Hemodialysis Trials.

O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC.

J Am Coll Cardiol. 2018 Jun 19;71(24):2802-2810. doi: 10.1016/j.jacc.2018.04.012. Review.

14.

Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group.

Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e008834. doi: 10.1161/JAHA.118.008834. No abstract available.

15.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

16.

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants .

Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060. No abstract available.

17.

Beta blockers in patients with end-stage renal disease-Evidence-based recommendations.

Weir MA, Herzog CA.

Semin Dial. 2018 May;31(3):219-225. doi: 10.1111/sdi.12691. Epub 2018 Feb 26. Review.

PMID:
29482260
18.

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.

PMID:
29459980
19.

Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study.

Wetmore JB, Molony JT, Liu J, Peng Y, Herzog CA, Collins AJ, Gilbertson DT.

J Am Heart Assoc. 2018 Feb 13;7(4). pii: e007231. doi: 10.1161/JAHA.117.007231.

20.

Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients.

Wetmore JB, Li S, Molony JT, Guo H, Herzog CA, Gilbertson DT, Peng Y, Collins AJ.

Am J Kidney Dis. 2018 Jan;71(1):123-132. doi: 10.1053/j.ajkd.2017.08.023. Epub 2017 Nov 20.

PMID:
29162336
21.

Renal Dysfunction Influences the Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin I.

Gunsolus I, Sandoval Y, Smith SW, Sexter A, Schulz K, Herzog CA, Apple FS.

J Am Soc Nephrol. 2018 Feb;29(2):636-643. doi: 10.1681/ASN.2017030341. Epub 2017 Oct 27.

22.

Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.

Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H.

Am J Kidney Dis. 2017 Dec;70(6):859-868. doi: 10.1053/j.ajkd.2017.08.003. Epub 2017 Sep 21. Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578-579.

PMID:
28941763
23.

Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.

Asinger RW, Shroff GR, Simegn MA, Herzog CA.

Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). pii: e003669. doi: 10.1161/CIRCOUTCOMES.117.003669. No abstract available.

PMID:
28893833
24.

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Kidney Int. 2017 Jul;92(1):26-36. doi: 10.1016/j.kint.2017.04.006. Review. Erratum in: Kidney Int. 2017 Dec;92(6):1558.

25.

Trends in Discharge Claims for Acute Myocardial Infarction among Patients on Dialysis.

Shroff GR, Li S, Herzog CA.

J Am Soc Nephrol. 2017 May;28(5):1379-1383. doi: 10.1681/ASN.2016050560. Epub 2017 Feb 20.

26.

Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.

Shafi T, Sozio SM, Luly J, Bandeen-Roche KJ, St Peter WL, Ephraim PL, McDermott A, Herzog CA, Crews DC, Scialla JJ, Tangri N, Miskulin DC, Michels WM, Jaar BG, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Medicine (Baltimore). 2017 Feb;96(5):e5924. doi: 10.1097/MD.0000000000005924.

27.

Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.

Rheault MN, Molony JT, Nevins T, Herzog CA, Chavers BM.

Kidney Int. 2017 Jan;91(1):177-182. doi: 10.1016/j.kint.2016.09.013. Epub 2016 Nov 16.

PMID:
27865440
28.

Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease.

deFilippi CR, Herzog CA.

Clin Chem. 2017 Jan;63(1):59-65. doi: 10.1373/clinchem.2016.254748. Epub 2016 Nov 3. Review.

30.

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2.

Herzog CA.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2095-2096. Epub 2016 Oct 25. No abstract available.

31.

T-Wave Alternans, Heart Rate Turbulence, and Ventricular Ectopy in Standard versus Daily Hemodialysis: Results from the FHN Daily Trial.

Kaplan RM, Herzog CA, Larive B, Subacius H, Nearing BD, Verrier R, Passman RS.

Ann Noninvasive Electrocardiol. 2016 Nov;21(6):566-571. doi: 10.1111/anec.12354. Epub 2016 Mar 28.

PMID:
27778458
32.

The US Renal Data System "Pie Chart of Death".

Herzog CA, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2016 Dec;68(6):986. doi: 10.1053/j.ajkd.2016.08.015. Epub 2016 Sep 20. No abstract available.

PMID:
27663038
33.

Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations.

Shroff GR, Herzog CA.

J Am Soc Nephrol. 2016 Dec;27(12):3521-3529. Epub 2016 Aug 4. Review.

34.

Predialysis volume overload and patient-reported sleep duration and quality in patients receiving hemodialysis.

Abreo AP, Dalrymple LS, Chertow GM, Kaysen GA, Herzog CA, Johansen KL.

Hemodial Int. 2017 Jan;21(1):133-141. doi: 10.1111/hdi.12446. Epub 2016 Jun 27.

PMID:
27346666
35.

Temporal trends in ischemic stroke and anticoagulation therapy for non-valvular atrial fibrillation: effect of diabetes.

Shroff GR, Solid CA, Bloomgarden Z, Halperin JL, Herzog CA.

J Diabetes. 2017 Feb;9(2):115-122. doi: 10.1111/1753-0407.12392. Epub 2016 Apr 13.

PMID:
26929264
36.

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollock A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ.

J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. Epub 2016 Feb 25.

37.

Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.

Kruzan RM, Herzog CA, Wu A, Sang Y, Parekh RS, Matsushita K, Hwang S, Cheng A, Coresh J, Powe NR, Shafi T.

BMC Nephrol. 2016 Feb 20;17:18. doi: 10.1186/s12882-016-0230-x.

38.

Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients.

Sandoval Y, Herzog CA, Love SA, Cao J, Hu Y, Wu AH, Gilbertson D, Brunelli SM, Young A, Ler R, Apple FS.

Clin Chem. 2016 Apr;62(4):631-8. doi: 10.1373/clinchem.2015.251835. Epub 2016 Feb 4.

39.

Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.

Charytan DM, Foley R, McCullough PA, Rogers JD, Zimetbaum P, Herzog CA, Tumlin JA; MiD Investigators and Committees.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):721-34. doi: 10.2215/CJN.09350915. Epub 2016 Jan 13.

40.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):539-46. doi: 10.2215/CJN.06370615. Epub 2015 Nov 27. Review.

41.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP.

Hemodial Int. 2016 Jul;20(3):421-31. doi: 10.1111/hdi.12382. Epub 2015 Nov 13.

42.

Administrative Data and the Philosopher's Stone: Turning Heart Failure Claims Data into Quantitative Assessment of Left Ventricular Ejection Fraction.

Bovitz T, Gilbertson DT, Herzog CA.

Am J Med. 2016 Feb;129(2):223-5. doi: 10.1016/j.amjmed.2015.10.003. Epub 2015 Oct 28.

PMID:
26519615
43.

Trends in Mortality Following Acute Myocardial Infarction Among Dialysis Patients in the United States Over 15 Years.

Shroff GR, Li S, Herzog CA.

J Am Heart Assoc. 2015 Oct 12;4(10):e002460. doi: 10.1161/JAHA.115.002460.

44.

Bad things come to those who wait: Dialysis, sudden death, and the long interdialytic period.

Passman RS, Herzog CA.

Heart Rhythm. 2015 Oct;12(10):2056-7. doi: 10.1016/j.hrthm.2015.07.022. Epub 2015 Jul 15. No abstract available.

PMID:
26188252
45.

Estimated pulmonary artery systolic pressure and self-reported physical function in patients on hemodialysis.

Abreo AP, Herzog CA, Kutner NG, Lea J, Johansen KL.

Am J Nephrol. 2015;41(4-5):313-9. doi: 10.1159/000431334. Epub 2015 Jun 13.

46.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

PMID:
26059012
47.

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Chang TI, Abdalla S, London GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Dehmel B, Goodman WG, Chertow GM.

J Hum Hypertens. 2016 Mar;30(3):204-9. doi: 10.1038/jhh.2015.56. Epub 2015 Jun 4.

PMID:
26040438
48.

Impact of acute coronary syndromes on survival of dialysis patients following surgical or percutaneous coronary revascularization in the United States.

Shroff GR, Solid CA, Herzog CA.

Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):205-13. doi: 10.1177/2048872615574106. Epub 2015 Mar 2.

PMID:
25732241
49.

Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.

Washam JB, Herzog CA, Beitelshees AL, Cohen MG, Henry TD, Kapur NK, Mega JL, Menon V, Page RL 2nd, Newby LK; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics and Translational Biology, Council on the Kidney in Cardiovascular Disease, and Council on Quality of Care and Outcomes Research.

Circulation. 2015 Mar 24;131(12):1123-49. doi: 10.1161/CIR.0000000000000183. Epub 2015 Feb 23. Review. No abstract available.

PMID:
25712269
50.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

Supplemental Content

Loading ...
Support Center